DNA peer analysis
Ginkgo (DNA) against its competitors: price, today's move, 1-year return and market value side by side.
DNA and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ARVN Arvinas | $6.39 | -2.44% | -33.23% | $412.29M |
| AVBP ArriVent BioPharma | $13.52 | 10.58% | -26.22% | – |
| IOVA Iovance | $8.05 | 3.95% | 344.50% | $3.64B |
| MBX MBX Biosciences | $51.35 | 5.96% | 127.72% | – |
| MGTX MeiraGTx | $9.00 | 5.76% | 4.90% | $864.39M |
| MRVI Maravai LifeSciences | $7.67 | 9.89% | 167.25% | – |
| REPL Replimune | $21.61 | 7.94% | 140.91% | $2.05B |
| VALN Valneva | $5.64 | 0.18% | -37.33% | – |
| VIR Vir Biotechnology | $12.32 | 11.81% | 128.17% | $2.08B |
| DNA Ginkgo | $11.39 | 14.38% | -1.70% | – |
- DNA's peers: ARVN (Arvinas), AVBP (ArriVent BioPharma), IOVA (Iovance), MBX (MBX Biosciences), MGTX (MeiraGTx), MRVI (Maravai LifeSciences), REPL (Replimune), VALN (Valneva).
Updated 2026-11-07 11:53 UTC